GROUPE BERKEM |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.805 EUR | +1.40% |
|
-0.82% | -41.01% |
| Sales 2024 * | 59M 63.5M | Sales 2025 * | 65.15M 70.12M | Capitalization | 31.32M 33.71M |
|---|---|---|---|---|---|
| Net income 2024 * | 1M 1.08M | Net income 2025 * | 3M 3.23M | EV / Sales 2024 * | 0.95 x |
| Net Debt 2024 * | 25M 26.91M | Net Debt 2025 * | 26.2M 28.2M | EV / Sales 2025 * | 0.88 x |
| P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
8.09
x | Employees | 200 |
| Yield 2024 * |
1.69% | Yield 2025 * |
4.49% | Free-Float | 31.79% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +1.40% | ||
| 1 week | -0.82% | ||
| Current month | +2.56% | ||
| 1 month | -22.53% | ||
| 3 months | -4.75% | ||
| 6 months | -43.59% | ||
| Current year | -41.01% |
1 week
1.76
1.84
1 month
1.762.38
Current year
1.353.70
1 year
1.185.00
3 years
1.1810.50
5 years
1.1810.50
10 years
1.1810.50
| Managers | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
Fahy Stanislas
BRD | Director/Board Member | - | 21-03-07 |
Lambert Thierry
BRD | Director/Board Member | - | 21-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 1.805 | +1.40% | 2 383 |
| 24-07-02 | 1.78 | -2.20% | 751 |
| 24-07-01 | 1.82 | +3.41% | 6,791 |
| 24-06-28 | 1.76 | -1.40% | 2,862 |
| 24-06-27 | 1.785 | -1.92% | 7,318 |
Real-time Euronext Paris, July 03, 2024 at 04:48 am EDT
More quotes
Berkem Group is a chemical group organized around 4 business units:
- production of active ingredients: from the extraction of plant materials. In addition, the group offers freeze-drying services for the food, cosmetics, nutraceutical and pharmaceutical industries, etc.;
- formulation of solutions for the preservation and protection of materials: in particular wood materials;
- distribution of solutions for the treatment, machining and protection of wood materials;
- manufacture of alkyd resins: for the paint, construction, wood treatment and ink industries.
At the end of 2023, the company has 3 production sites located in France.
France accounts for 71.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-07-24
- Q2 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.78
EUR
Average target price
4.45
EUR
Spread / Average Target
+150.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -41.01% | 33.63M | |
| +55.55% | 816B | |
| +40.02% | 634B | |
| -6.83% | 351B | |
| +17.15% | 323B | |
| +7.09% | 293B | |
| +13.51% | 238B | |
| +1.39% | 222B | |
| +13.20% | 218B | |
| +7.87% | 167B |
- Stock Market
- Equities
- ALKEM Stock
